Skip to main content

Press Releases

male scientist in laboratory
Read more
folded bandages
PRESS RELEASE 15 Oct 2021 at 17:55

U.S. FDA Approves Cyltezo® (adalimumab-adbm) as First Interchangeable Biosimilar with Humira®

Read more
Read more
newspapers stacked on top of news sign
PRESS RELEASE 14 May 2019 at 08:35

Boehringer Ingelheim announces resolution of Cyltezo® patent litigation

Read more
Read more
newspapers stacked on top of news sign
PRESS RELEASE 31 Oct 2018 at 11:00

Boehringer Ingelheim Announces Growth in the Bay Area

Read more
Read more
PRESS RELEASE 29 Aug 2017 at 09:13

Boehringer Ingelheim Pharmaceuticals, Inc. receives FDA approval for CyltezoTM (adalimumab-adbm), a biosimilar to Humira®, for the treatment of multiple chronic inflammatory diseases

Read more
Read more
newspapers stacked on top of news sign
PRESS RELEASE 27 Jul 2017 at 09:10

Boehringer Ingelheim starts clinical study on interchangeability between its adalimumab biosimilar candidate and U.S.-formulated Humira®

Read more
Read more
rsp
PRESS RELEASE 21 Jul 2017 at 15:06

Boehringer Ingelheim Breaks Ground on $217 Million Expansion of Fremont, California Manufacturing Facility

Read more
Read more
Saniona and Boehringer Ingelheim sign collaboration agreement in schizophrenia
BOEHRINGER INGELHEIM STATEMENT

Boehringer Ingelheim Statement: Favorable Ruling on Humira® Patent Challenge from U.S. Patent and Trademark Office

Read more
Read more
PRESS RELEASE 18 Jan 2017 at 09:00

Boehringer Ingelheim biosimilar candidate to Humira® accepted for EMA and FDA regulatory review

Read more